Rock Springs Capital Management LP Fusion Pharmaceuticals Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.49 - $7.86 $344,797 - $1.09 Million	-138,473 Reduced 14.6%	809,854 $2.02 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $13.73 $9,039 - $10,791	786 Added 0.08%	948,327 $11.1 Million
Q3 2020 Nov 16, 2020	BUY	$11.8 - $17.1 $123,900 - $179,550	10,500 Added 1.12%	947,541 $11.4 Million
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $15.9 Million - $16.7 Million	937,041 New	937,041 $16.4 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.